Category: Health & Science

NEW DELHI (Wednesday, March 25, 2026) — A landmark study published in The Lancet Regional Health Southeast Asia has revealed that antibiotic-resistant typhoid infections are no longer just a medical crisis but a massive economic one for India. In 2023, these resistant strains accounted for 87% of the country’s total disease-related economic burden, which has reached a staggering ₹123 billion ($1.5 billion).

---

The Economic Crisis for Households

The study, conducted by researchers from the London School of Hygiene and Tropical Medicine (LSHTM) and Christian Medical College (CMC), Vellore, highlights a severe disparity in who pays for treatment.

• Out-of-Pocket Dominance: Households bore a massive 91% of the total expenses.
• Catastrophic Expenditure: Approximately 70,000 families faced “catastrophic” health spending—defined as medical costs exceeding 40% of a household’s non-subsistence income, threatening their ability to afford food or housing.
• Productivity Loss: Beyond direct medical bills, the study estimated a productivity loss of more than ₹4,200 crore due to illness-related absence from work.

Vulnerable Groups and Hotspots

The data shows that the burden is not distributed evenly across the population or geography.

Category	Finding
Most Affected Age	Children under 10 incurred over half of the national economic burden.
Primary Resistance	Fluoroquinolone resistance is the main driver, accounting for 82% of all hospitalizations.
High-Burden States	Maharashtra, Uttar Pradesh, Andhra Pradesh (incl. Telangana), Tamil Nadu, and West Bengal account for 51% of national costs.

The “Fluoroquinolone” Factor

Fluoroquinolones were once the “gold standard” for treating severe typhoid because they could reduce fever within four days. However, the study found that 87% of total costs are now linked specifically to fluoroquinolone-resistant infections, which lead to:

1. Longer Hospital Stays: Patients stay in wards significantly longer as doctors struggle to find effective alternative drugs.
2. Expensive Alternatives: Shift to “third-generation cephalosporins” or azithromycin, which are more costly and often require intravenous administration.

---

Call for National Vaccination

The authors, including Dr. Vijayalaxmi Mogasale (LSHTM) and Professor Jacob John (CMC Vellore), argue that these findings provide the “missing evidence” needed for policy shifts.

• Typhoid Conjugate Vaccine (TCV): The study strongly supports the immediate introduction of the TCV into India’s Universal Immunisation Programme.
• Targeted Strategy: Given the high burden in specific states like Maharashtra and Delhi, researchers suggest a phased roll-out starting in high-burden metropolitan areas.
• Policy Shift: The findings urge a move toward social health insurance expansion to protect families from falling into poverty due to a preventable infectious disease.

Sources

• The Lancet Regional Health – Southeast Asia: “Economic burden of typhoid fever by antimicrobial resistance in India: a modelling study 2023” (Published March 2026).
• Press Trust of India (PTI): “Antibiotic resistance fuels 87 per cent of India’s typhoid economic burden: Study” (March 25, 2026).
• The Hindu: “Antibiotic resistance fuels 87% of India’s typhoid economic burden” (March 25, 2026).
• LSHTM News: “Typhoid fever costs billions for India’s economy and people” (March 24, 2026).

NEW DELHI (Wednesday, March 25, 2026) — A groundbreaking global analysis published in the journal Nature Microbiology has identified a direct link between soil aridity (dryness) and the proliferation of antibiotic-resistant bacteria. The study, led by researchers at the California Institute of Technology (Caltech), suggests that climate change—specifically increasing drought conditions—is an overlooked driver of the global antibiotic resistance crisis.

---

The Mechanism: Survival of the Fittest in Dry Soil

The study explains that as soil dries out due to drought, the microbial ecosystem undergoes a dramatic “arms race” for survival.

• Natural Antibiotic Production: In dry, resource-scarce soil, certain fungi and bacteria increase their production of natural antibiotics to kill off competitors and secure limited nutrients.
• Selection Pressure: This surge in natural antibiotics acts as a selection pressure. Only the bacteria that possess or develop Antibiotic Resistance Genes (ARGs) can survive.
• Horizontal Gene Transfer: These resistant bacteria then share their survival blueprints with other microbes, leading to a higher concentration of “superbugs” in the environment.

Global Data Analysis

The research team conducted a massive cross-referencing exercise, comparing clinical data with environmental metrics across 116 countries.

Data Point	Source / Metric	Finding
Clinical Isolates	Hospital data from 116 countries	Average frequency of resistance in common pathogens (e.g., E. coli).
Environmental Aridity	Yearly precipitation & mean temperature	Regions with higher “Aridity Index” (drier climates).
Correlation	Statistical Analysis	Higher aridity consistently associated with higher rates of antibiotic resistance in local hospitals.

The Climate-Health Connection

The researchers highlighted that this is not just an environmental issue but a direct threat to human medicine.

1. Environmental Pathways: Resistant bacteria from dry soil can reach humans through dust storms, water runoff during flash floods following a drought, or through the food chain (crops grown in arid soil).
2. Climate Change Impact: As global temperatures rise and rainfall patterns become more erratic, more regions are becoming “arid,” potentially creating new hotspots for antibiotic resistance.
3. Hospitals as Reflectors: The fact that hospital data mirrors local soil dryness suggests that the environment plays a much larger role in clinical resistance than previously thought, moving beyond the simple “overuse of medicine” narrative.

---

Sources

• Nature Microbiology: “Global aridity is associated with higher frequency of antibiotic resistance in clinical isolates” (Published March 2026).
• Caltech News: “How Drought in the Dirt Leads to Superbugs in the Clinic” (March 25, 2026).
• The Guardian: “Climate change-driven soil dryness linked to global rise in antibiotic resistance” (March 25, 2026).
• Press Trust of India (PTI): “Study reveals link between soil dryness, antibiotic-resistant bacteria” (March 25, 2026).

NEW DELHI (Wednesday, March 25, 2026) — The Municipal Corporation of Delhi (MCD) is exploring a landmark shift in its healthcare infrastructure by proposing its first-ever medical college under a Public-Private Partnership (PPP) model. The project is slated for a vacant 15-acre plot within the Rajan Babu Institute of Pulmonary Medicine and Tuberculosis (RBIPMT) campus in North Delhi’s Kingsway Camp.

---

The Strategic Shift: Why a PPP Model?

Faced with a high demand for medical seats and limited capital for large-scale infrastructure, the MCD is looking to leverage private expertise and funding.

• Infrastructure Goal: To establish a full-fledged medical college along with a newly developed affiliated multi-specialty hospital on the existing TB hospital campus.
• Financial Sustainability: Under the PPP model, a private partner would likely handle the construction and operational management, while the MCD provides the land and retains oversight.
• Clinical Exposure: Students at the proposed college would benefit from the specialized clinical environment of the Rajan Babu TB Hospital, one of the largest tuberculosis specialty centers in Asia.

Project Timeline and Status

The proposal was originally scheduled for discussion during the MCD Standing Committee meeting on Wednesday, March 25.

Milestone	Status
Initial Proposal	Drafted by MCD Health Department (March 2026)
Standing Committee Review	Deferred (Meeting on March 25 was cancelled)
Next Scheduled Hearing	March 30, 2026
Expected Capacity	Estimated 100–150 MBBS seats (subject to NMC approval)

Context: Expanding North Delhi’s Medical Hub

Kingsway Camp is already a significant medical corridor, housing the Vardhman Mahavir Medical College (at Safdarjung, though technically south) and being near North Delhi Municipal Corporation Medical College (Hindu Rao).

• Hindu Rao Precedent: While the MCD already runs the Hindu Rao Medical College, that institution is entirely state-funded. This new project would mark the transition toward a “hybrid” administrative model.
• Urban Renewal: Utilizing the vacant land at the Rajan Babu campus is part of a larger plan to modernize colonial-era hospital grounds into high-tech medical hubs.

---

Sources

• The Times of India: “MCD to explore PPP model for new medical college in north Delhi’s Kingsway Camp” (March 25, 2026).
• Hindustan Times: “Civic body mulls first private-partnered medical college in Delhi” (March 26, 2026).
• The Hindu: “MCD’s proposal for medical college on PPP mode to be tabled on March 30” (March 25, 2026).
• Official MCD Press Release: “Developmental Projects for Health Infrastructure” (Ref: MCD/PR/2026/084).

NEW DELHI (Wednesday, March 25, 2026) — Three years after India implemented a nationwide ban on several single-use plastic (SUP) items, a new study has revealed that the prohibited products remain rampant in major cities. Delhi has emerged as one of the worst-performing cities, with banned plastics found at 86% of surveyed locations, highlighting a significant “toothless” enforcement gap.

---

Key Findings: The “Revisiting Single Use Plastic Ban” Report

The study, titled “Revisiting Single Use Plastic Ban,” was conducted by the environmental research group Toxics Link. Researchers surveyed 560 locations—including street vendors, markets, and transit hubs—between April and August 2025.

• Overall Non-Compliance: Prohibited plastic items were present in 84% of all surveyed sites across four major Indian cities.
• The “Worst” Performers: While Delhi’s 86% violation rate is alarming, Bhubaneswar recorded the highest availability at 89%.
• Sectoral Divide: While organized retail spaces and malls showed better adherence, informal markets and small vendors showed “near-complete presence” of banned items.

City-Wise Violation Rates

City	Violation Rate (%)	Rank (Worst to Best)
Bhubaneswar	89%	1
Delhi	86%	2
Mumbai	85%	3
Guwahati	76%	4

Why is the Ban Failing?

The report identifies several systemic barriers that prevent effective implementation:

1. High Customer Demand: 91% of small vendors reported that customers still explicitly ask for plastic carry bags.
2. Cost Advantage: Vendors cited the significantly higher cost of alternatives (paper, cloth, or compostable materials) as the primary reason for sticking to plastic.
3. Hygiene Perceptions: Many consumers perceive disposable plastic cutlery and plates as more “hygienic” than reusable steel or glass items.
4. Enforcement Gaps: The study found that while the ban exists on paper, regular inspections and penalties are inconsistent, allowing the supply chain to remain active.

---

What Items are Currently Banned?

The 2022 nationwide ban targets 19 items with “low utility and high littering potential,” including:

• Plastic sticks (earbuds, balloons, ice cream, candy).
• Cutlery (plates, cups, glasses, forks, spoons, knives, straws, trays).
• Packaging films (around sweet boxes, invitation cards, cigarette packets).
• PVC banners less than 100 microns.
• Carry bags less than 120 microns in thickness.

Sources

• The Hindu: “Toothless ban: Single-use plastic rules 84% of surveyed sites in four cities” (March 26, 2026).
• Hindustan Times: “Delhi among worst performers in single-use plastic ban compliance: Study” (March 25, 2026).
• Toxics Link Official Report: “Revisiting Single Use Plastic Ban” (Released March 25, 2026).
• PTI News: “Delhi records persistent gaps in single-use plastic enforcement” (March 25, 2026).

NEW DELHI (Thursday, March 26, 2026) — A groundbreaking study published in the journal Science Advances has revealed that metformin, the world’s most widely prescribed diabetes medication, works by targeting a previously unknown pathway in the brain. For over 60 years, it was believed the drug acted solely on the liver and gut; however, this discovery identifies the brain as a “command center” for its glucose-lowering effects.

---

The Discovery: The Rap1-Hypothalamus Axis

Researchers at Baylor College of Medicine, led by Dr. Makoto Fukuda, identified a specific molecular “switch” in the brain that allows metformin to function at much lower doses than previously thought necessary.

• The Target Region: The study focused on the ventromedial hypothalamus (VMH), a part of the brain responsible for sensing glucose and regulating satiety.
• The Molecular Switch: A protein called Rap1 was found to be the key mediator. Metformin works by suppressing Rap1 activity in the VMH.
• Neural Activation: When Rap1 is inhibited, it activates a specific group of brain cells called SF1 neurons, which then send signals to the rest of the body to lower blood sugar.

[Image: Diagram of the human brain highlighting the Hypothalamus and the signaling pathway to the liver]

Key Evidence from the Study

The research team used genetically engineered models to prove that the brain is indispensable for metformin’s action.

Experiment Type	Methodology	Result
Genetic Knockout	Mice were bred without the Rap1 protein in their brain’s VMH.	Metformin failed to lower blood sugar, even though other drugs like insulin still worked.
Direct Brain Injection	Tiny doses of metformin were injected directly into the brains of diabetic mice.	Blood sugar dropped significantly at doses thousands of times lower than typical oral doses.
Sensitivity Comparison	Compared the brain’s response to the liver and gut’s response.	The brain reacted to much lower concentrations, suggesting it is a primary site of action.

Implications for the Future

This shift in understanding opens new therapeutic doors for treating type 2 diabetes and potentially other neurological conditions.

1. Targeted Therapies: Future drugs could be designed to target the VMH Rap1 pathway directly, potentially reducing the side effects (like gastrointestinal distress) associated with high oral doses of metformin.
2. Anti-Aging Potential: Metformin is already widely studied for its geroprotective (anti-aging) benefits. Dr. Fukuda’s team plans to investigate if this same Rap1 signaling is responsible for the drug’s ability to slow brain aging and improve longevity.
3. Refined Prescribing: Doctors can now better understand why low doses of metformin are effective for some patients, as the brain-based mechanism is highly sensitive.

---

Sources

• ScienceDaily: “Metformin’s hidden brain pathway revealed after 60 years” (March 25, 2026).
• The Week: “Diabetes drug’s 60-year mystery solved: Scientists finally discovered how metformin works” (March 26, 2026).
• Science Advances: Lin et al., “Low-dose metformin requires brain Rap1 for its antidiabetic action” (Originally published 2025; Updated March 2026).
• Baylor College of Medicine News: “Researchers uncover a new player mediating metformin’s anti-diabetic action” (March 26, 2026).

A modeling study published in PLOS Medicine on February 20, 2026, warns of a staggering economic fallout from recent and projected cuts to U.S. foreign aid. Researchers from Boston University, the London School of Hygiene & Tropical Medicine, and Harvard University estimate that the termination of USAID support for tuberculosis (TB) programs will impose an additional $7.5 billion in costs on households in low- and middle-income countries (LMICs) by 2050.

The study highlights a grim reality for global health equity, noting that nearly 4 million additional households are projected to face “catastrophic costs”—expenditures exceeding 20% of their annual income—directly due to the loss of bilateral U.S. funding.

---

The Economic “Worst-Case” Scenario

While the $7.5 billion figure accounts for USAID termination alone, the researchers modeled more severe scenarios involving broader international funding collapses.

• Scenario A (USAID Only): $7.5 billion in added patient costs; 3.9 million more households face catastrophic expenses.
• Scenario B (USAID + US Global Fund Cuts): Costs jump to $24 billion if the U.S. also withdraws from the Global Fund to Fight AIDS, TB, and Malaria.
• Scenario C (Total International Withdrawal): In the absolute worst-case, the economic burden reaches $79.7 billion, with over 40 million households pushed into financial ruin.

Disproportionate Impact on the Poorest

The study utilized data from 79 LMICs, representing 91% of global TB cases, to map the burden across income levels.

Income Quintile	Share of Catastrophic Costs	Impact Description
Poorest 20%	>50%	The most vulnerable face the highest risk of “medical impoverishment.”
Middle 40%	~35%	Significant risk of debt-traps and asset depletion.
Wealthiest 40%	<15%	Better able to absorb direct costs, though still impacted by service loss.

---

The Mechanism of “Catastrophic Cost”

When international aid for diagnostics and treatment vanishes, the financial burden shifts directly to the patient in three major ways:

1. Direct Medical Costs: Paying for specialized TB drugs and laboratory tests that were previously subsidized.
2. Non-Medical Costs: Travel to distant clinics and specialized nutritional support required for recovery.
3. Indirect Costs (Income Loss): TB often prevents patients from working for months; without aid-funded “rapid-recovery” protocols, this lost income becomes a permanent economic setback.

[Image: A bar chart showing the projected increase in catastrophic costs by income quintile, with the largest bar representing the poorest 20% of the population.]

---

Key Takeaways

• Reversing Decades of Progress: USAID has historically funded nearly 20% of global TB services, helping prevent an estimated 75 million deaths since its inception.
• A “De Facto” Dissolution: The study comes amid the “dismantling” of USAID following an 83% budget cut announced by the second Trump administration in early 2025.
• The Domestic Pivot: Lead author Dr. Allison Portnoy stresses that LMICs must now urgently strengthen domestic financing and integrate TB services into primary healthcare to survive the “funding cliff.”

---

Sources

• PLOS Medicine: The potential impact of reduced international donor funding on the household economic burden of tuberculosis, Feb 20, 2026.
• Boston University SPH: Foreign Aid Cuts to TB Services Could Cost Families $80 Billion Worldwide, March 11, 2026.
• Press Trust of India (PTI): Cuts to USAID could generate USD 7.5 bn additional costs, March 13, 2026.

In a landmark discovery reported on March 13, 2026, a team of international researchers, including key contributors from Flinders University (Australia), has unveiled a novel chemical reaction named “Trisulfide Metathesis.” This reaction allows for the spontaneous making and breaking of sulphur-sulphur (S-S) bonds at room temperature without the need for external catalysts, heat, or light. Published in the prestigious journal Nature Chemistry, the discovery is being hailed as a “missing link” in synthetic chemistry, with the potential to transform drug delivery, protein engineering, and the creation of truly circular, recyclable plastics.

---

The Science: Breaking the “Sulphur Barrier”

Sulphur-sulphur bonds are the “molecular glue” of the biological world, providing structural stability to everything from human hair (keratin) to life-saving proteins like insulin. Historically, these bonds have been notoriously difficult to manipulate selectively; they usually require harsh chemical reagents or high energy.

The “Trisulfide” Difference:

Unlike standard disulfides, the researchers focused on trisulfides (chains of three sulphur atoms). They found that when exposed to certain “polar aprotic” solvents, these molecules undergo a metathesis reaction—essentially a high-speed “partner swap”—where bonds break and reform in seconds.

• Speed: In some cases, the reaction reaches equilibrium almost instantly at room temperature.
• Selectivity: The process allows scientists to modify specific parts of a complex molecule without damaging the rest of its structure.

---

Impact Across Industries

Industry	Potential Application
Drug Development	Anti-cancer drug modification: Precise “tagging” of drugs to improve targeting and reduce side effects.
Protein Science	Protein Folding: Better understanding of how S-S bonds stabilize proteins, aiding in the treatment of misfolding diseases (e.g., Alzheimer’s).
Biotechnology	Bioconjugation: Easier attachment of fluorescent markers or payloads to antibodies for diagnostic imaging.
Material Science	Recyclable Polymers: Creation of “polyethylene analogs” that can be broken back down into their original building blocks at room temperature.

---

The “Circular Economy” of Plastics

One of the most exciting outcomes is the development of chemically recyclable polymers. Traditional plastics are difficult to recycle because their carbon-carbon bonds are too strong. By incorporating the trisulfide metathesis reaction:

1. Assembly: Polymers are formed into durable materials.
2. Disassembly: By triggering the metathesis reaction, the plastic “unzips” back into its original monomers.
3. Result: A closed-loop system where plastic can be recycled indefinitely without losing quality.

[Image: A schematic showing a trisulfide chain (S-S-S) undergoing a ‘partner swap’ to form new molecular configurations at 25°C.]

---

Key Takeaways

• Zero-Stimulus Reaction: Works at room temperature without the need for UV light or toxic metal catalysts.
• High Efficiency: The reaction is “clean,” producing minimal byproducts, which is a core tenet of Green Chemistry.
• Broad Utility: Successfully tested on a variety of natural products and existing anti-cancer pharmaceutical libraries.

---

Sources

• Nature Chemistry: The Spontaneous Metathesis of Organic Trisulfides, March 2026.
• Flinders University Press Release: Groundbreaking Sulphur Reaction Unlocked, March 13, 2026.
• Press Trust of India (PTI): New Chemical Reaction Opens Drug Development Avenues, March 13, 2026.

In a significant medical advancement reported from Jaipur on March 12, 2026, experts are highlighting the “growing implant” as a transformative treatment for children suffering from bone cancer (Osteosarcoma). Dr. Praveen Gupta, an orthopaedic oncologist at Bhagwan Mahaveer Cancer Hospital, noted that these specialized prostheses address the primary challenge of pediatric surgery: the fact that children’s bones continue to elongate while traditional metal implants remain static.

---

The Medical Challenge: Growth Plate Destruction

When bone cancer occurs near a joint, surgeons often must remove the epiphyseal plate (the growth plate). In a growing child, this leads to a “limb-length discrepancy,” where the healthy leg continues to grow while the operated leg remains short, leading to lifelong mobility issues and spinal misalignment.

How the Technology Works

The “growing” or expandable prosthesis is an internal implant designed to be lengthened periodically without the need for invasive, repeated surgeries.

• The Mechanism: The implant contains a small internal motor or a magnetic expansion screw.
• Non-Invasive Expansion: Doctors use an external Electromagnetic Actuator (a specialized ring placed over the limb) to trigger the internal motor.
• Precision: The limb can be lengthened by as little as 1 mm to 2 mm during a routine outpatient visit, matching the natural growth rate of the child’s opposite limb.

---

Comparison: Traditional vs. Growing Implants

Feature	Traditional Implants	Growing Implants (Expandable)
Suitability	Best for adults (skeletally mature).	Designed specifically for growing children.
Surgical Load	Requires “revision surgery” to replace the limb as it’s outgrown.	No additional surgery required for lengthening.
Patient Comfort	High risk of limping and back pain.	Maintains symmetry and normal gait.
Recovery	Long recovery after every replacement.	Minimal downtime; lengthening is painless.

---

Clinical Impact and Industry Adoption

While the technology was once prohibitively expensive and required manual “cranking” via small incisions, the modern non-invasive magnetic versions have reduced infection rates and psychological trauma for young patients.

• Bone Salvage: This technique is a cornerstone of Limb Salvage Surgery (LSS), which has largely replaced amputation in over 80% to 90% of bone cancer cases.
• Psychological Benefits: Maintaining a “normal” appearance and functional parity with peers significantly improves the mental health outcomes of pediatric cancer survivors.

---

Key Takeaways

• Adaptive Design: The implant mimics natural biological growth using magnetic technology.
• Reduced Trauma: Eliminates the “surgical cycle” where children previously faced 5–10 operations before adulthood.
• Precision Oncology: Allows for aggressive tumor removal while guaranteeing functional restoration.

---

Sources

• The Times of India: Growing Implant Emerging as New Treatment, March 12, 2026.
• Journal of Bone and Joint Surgery (JBJS): Advancements in Magnetically Expandable Prosthetics, 2025 Edition.
• Bhagwan Mahaveer Cancer Hospital Research Wing: Clinical Outcomes of Pediatric LSS, February 2026.

In a written response to the Lok Sabha on March 12, 2026, the Union Minister of State for Tribal Affairs, Durgadas Uikey, confirmed several isolated instances of suspected food poisoning and infections within Eklavya Model Residential Schools (EMRS). The disclosure came following inquiries from Congress MP Mallu Ravi regarding the safety of students in these federally funded institutions. While the government maintains that “appropriate corrective measures” were taken, the incidents have triggered a nationwide push for stricter hygiene protocols in school messes and hostels.

---

The Institutional Response

Minister Uikey emphasized that the National Education Society for Tribal Students (NESTS), which operates under the Ministry of Tribal Affairs, has already deployed a comprehensive safety framework to prevent future outbreaks. Key interventions include:

• Medical Oversight: Mandatory engagement of a Staff Nurse and Counsellor in every EMRS to monitor student health and provide psychosocial support.
• Emergency Logistics: Provisions for hiring dedicated school vehicles to ensure students can be rushed to nearby healthcare facilities during medical emergencies.
• Professional Consultation: The mandate for part-time doctors to conduct periodic medical check-ups and provide on-site consultations.

The “Mess Management” Protocol

To curb the risk of contamination, the government highlighted the EMRS Mess Management Guidelines, which dictate a strict chain of custody for food.

Feature	Requirement
Food Tasting	Mandatory tasting by school authorities prior to serving students.
Oversight Committees	Constitution of Mess Committees involving student representatives.
Storage Standards	Strict adherence to safe storage and kitchen cleanliness.
Periodic Audits	Regular inspections by State/UT EMRS Societies to ensure compliance.

---

Timeline of Safety Failures

While the Minister characterized these as “isolated instances,” recent data shows a recurring pattern of health emergencies in these residential settings:

• January 19-20, 2026: 43 students in Gujarat’s Banaskantha district were hospitalized after a midday meal caused widespread vomiting and diarrhea.
• Early March 2026: Reports emerged from Kothagudem (Telangana) where over two dozen students fell ill after a hostel lunch.
• March 12, 2026: Formal government acknowledgment in the Lok Sabha.

[Image: A breakdown of the NESTS safety hierarchy, showing the reporting line from the Mess Committee to the State EMRS Society.]

---

Key Takeaways

• Administrative Accountability: Corrective actions are being managed by State/UT EMRS Societies in coordination with local health departments.
• Preventive Infrastructure: NESTS is shifting toward a model of “continuous monitoring” rather than reactive treatment.
• Focus on Vulnerable Groups: As these schools serve Scheduled Tribe (ST) communities, the Ministry is under pressure to ensure that institutional care matches the standards of urban private boarding schools.

---

Sources

• Press Information Bureau (PIB): Safety Standards in Tribal Residential Schools, March 12, 2026.
• Press Trust of India (PTI): Government Confirms Suspected Food Poisoning in EMRS, March 13, 2026.
• The Wire/The Logical Indian: Reports on Banaskantha Hospitalizations, January 2026.

---

The Medical Challenge: “Severe Acute Flexion Deformity”

The patient had been living with Rheumatoid Arthritis for over 15 years. Due to delayed intervention, her condition progressed into a rare and extreme state:

• The Deformity: Both her knees were permanently locked in a bent position at an angle exceeding 90 degrees.
• Physical Toll: This “flexion deformity” meant she could neither straighten her legs nor bear her own weight, forcing her to crawl for several years.
• Surgical Risk: Multiple hospitals had previously declined to operate. The case was considered “inoperable” by many due to the risk of damaging major nerves and blood vessels that had shortened and shifted because of the long-term deformity.

The Robotic Solution

The surgery was led by Dr. Vivek Logani, Director of Joint Replacement at Paras Health, who utilized advanced robotic navigation to overcome the anatomical challenges.

Feature of Surgery	Benefit to the Patient
3D CT-Based Planning	Allowed surgeons to map the distorted anatomy and plan sub-millimeter cuts before the first incision.
Robotic Precision	Enabled the surgeon to correct the 90-degree bend with extreme accuracy, preserving as much natural bone as possible.
Soft-Tissue Balancing	Robotic sensors provided real-time feedback, ensuring the ligaments were perfectly balanced to allow for a natural walking gait.
Nerve Protection	The controlled, robotic-assisted movements minimized the risk of stretching or snapping the critical nerves and vessels behind the knee.

Recovery Timeline

• Post-Op (Day 10): The patient achieved near-complete correction of the bend in her legs.
• 6 Weeks Later: After intensive rehabilitation and physiotherapy, she was able to walk independently without support.
• Long-Term Outlook: Doctors emphasized that while the surgery was a success, early diagnosis of Rheumatoid Arthritis remains critical to avoiding such life-altering disabilities.

---

Sources

• Press Trust of India (PTI): “62-year-old woman who could not stand walks again after complex surgery” (March 12, 2026)
• Hindustan Times: “Haryana woman who had to crawl for years walks again after robotic surgery” (March 12, 2026)
• Devdiscourse: “Robotic Breakthrough: Transforming Lives with Precision Knee Surgery” (March 11, 2026)